top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Autore Vermehren Charlotte
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (224 p.)
Soggetto topico Medicine
Pharmaceutical industries
Soggetto non controllato acute kidney injury
early biomarker
plasma neutrophil gelatinase-associated lipocalin
soluble urokinase plasminogen activator receptor
medication optimization
older patients
emergency department
multimorbidity
polypharmacy
potentially inappropriate medication use
older adults
prevalence
determinants
chronic
outpatient
2019 Beers criteria
Ethiopia
pharmacogenomics
persons with diabetes
drug–drug interactions
drug–gene interactions
cytochrome P450
SLCO1B1
drug interaction checkers
adverse drug reactions
pharmacogenetics
personalized medicine
phenprocoumon
DOACs
bleeding
thromboembolism
HLA
drug hypersensitivity
abacavir
allopurinol
flucloxacillin
antiepileptic drugs
cost-effectiveness
shared medication record
medication reconciliation
drug information service
hospital pharmacy service
electronic prescribing
electronic medical record
clinical pharmacist
CYP2D6
CYP2D7P
CYP2D8P
copy number variation
CNV
genotyping
5’nuclease assay
HRM
high resolution melting
drug metabolization
extracellular vesicles
exosomes
microvesicles
pharmacogene expression
medication review
deprescriptions
quality of life
aged
aged, 80 and over
nursing homes
deprescribing
medication-based risk score
health outcomes
cytochromes
CYP1A2
adverse drug reaction
antipsychotics
olanzapine
clozapine
loxapine
children
youth
digital decision-support
health services research
general practice
process evaluation
antidepressants
utility
population-based
appropriateness
medication adherence
digital health
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Record Nr. UNINA-9910595072903321
Vermehren Charlotte  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Treatment Strategies and Survival Outcomes in Breast Cancer
Treatment Strategies and Survival Outcomes in Breast Cancer
Autore Cheung Kwok-Leung
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (264 p.)
Soggetto non controllato relative survival
young women
cancer treatment
fulvestrant
lapatinib
tumor biology
antihormone therapy
mastectomy
aromatase inhibitors
chemotherapy
serum biomarker
cyclin E
anthracycline resistance
zero-inflated Poisson regression model
lymph-node ratio
CHEK2
comparative effectiveness
breast-conserving therapy
taxane sensitivity
liquid biopsy
HER2 c-erbB2
colorectal cancer
infiltrating breast cancer
survival
exercise characteristics
lactate dehydrogenase
biomarker
breast cancer survivors
BRCA
disease-free survival
PIK3CA
metastatic breast cancer
cell-free DNA
invasive breast cancer
radiotherapy
Metformin
social well-being
gene expression
contralateral breast cancer
basal-like breast cancer
LMK-235
Src kinase
HER2/neu
LKB1
Older women
LDH
mutation carriers
stage IV
mammography screening
NCDB
cMet
SEER
pertuzumab
physical function
outcome
ribociclib
older patients
geriatric oncology
metastatic
overdiagnosis
next-generation sequencing
abemaciclib
Endocrine therapy
monitoring metastatic breast cancer
breast cancer
circulating tumor cells
Breast Cancer
PALB2
histone deacetylase
prognosis
physical activity
trastuzumab
ductal carcinoma in situ
contralateral prophylactic mastectomy
ERCC1
family history
T-DM1
ATM
advanced breast cancer
incidence
palbociclib
HDAC5 inhibitors
APOBEC3B
ISBN 3-03928-759-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404084403321
Cheung Kwok-Leung  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui